This complaint is from a literature source.It was reported that 240 patients with af underwent catheter ablation from july 2013 and june 2015.Among them, 1 patient in group d developed hemoptysis, and the patient developed a large groin hematoma two days following the procedure and a high fever of 38.6°c.Dabigatran was discontinued imminently.Two days later, massive hemoptysis occurred and pulmonary computed tomography (ct) presented bilateral pulmonary frosted glass.At three days later, no hemoptysis occurred and a lung ct presented markedly reduced frosted glass.Based on the facts of the case and the author¿s assessment, there were no reported malfunction with any of the bwi catheters and systems used during the case.Thus, this event is unrelated to the device and most likely related to the procedure.Title: ¿use of dabigatran vs.Warfarin with low-molecular-weight heparin bridging in catheter ablation for atrial fibrillation patients with a low chads2 score¿.The purpose of this study was to compare the efficacy and safety of dabigatran and interrupted warfarin with low-molecular-weight heparin bridging in non-valvular atrial fibrillation (af) catheter ablation.Suspect device is a lasso catheter, however catalog and lot number is unknown.
|